|
Hearken to this text  |
The Monarch platform for robot-assisted urology procedures. | Supply: Johnson & Johnson’s Ethicon
Ethicon, a Johnson & Johnson MedTech firm, at present introduced the primary robotic-assisted elimination of kidney stones utilizing the Monarch platform.
Auris Well being, an Ethicon subsidiary, obtained FDA clearance for Monarch for endourological procedures in Might 2022. The College of California, Irvine’s UCI Well being used the Monarch platform for urology to finish the primary process.
Based on a information launch, it’s the primary profitable robotically assisted, electromagnetic-guided percutaneous entry and mini-percutaneous nephrolithotomy process. Ethicon stated its examine entails a collaboration with co-investigator Dr. Mihir Desai from the College of Southern California.
Robotics Summit & Expo (Might 10-11) returns to Boston
Martin Buehler, World Head of Robotics R&D at Johnson & Johnson MedTech, might be keynoting the Robotics Summit on Might 11, 2023, at 10 AM. Buehler’s speak, “The Way forward for Surgical Robotics”, will give an inside have a look at the end-to-end growth of its Monarch and Ottava robotics platforms, in addition to technique and innovation cadence throughout surgical robotics for MedTech.
“This scientific examine is the primary on the planet to analysis and exhibit the potential for improved navigation, entry, clearance and management in mini-PCNL procedures utilizing the Monarch platform for urology,” stated Dr. Jaime Landman, chair of the UCI College of Medication Division of Urology and director of the UCI Well being Kidney Stone & Kidney Illness Companies. “Along with doubtlessly serving to urologists obtain stone-free sufferers in a single process, this method may assist scale back the necessity for retreatment after kidney stone elimination and reduce dangers and complication charges.”
Ethicon’s scientific group led the primary case in its scientific examine. It goals to gather efficiency information on robotic mini-PCNL procedures to optimize Monarch and inform coaching and training.
“The prevalence of kidney stones stays excessive, and lots of urologists search a brand new remedy choice that reduces total retreatment and complication charges,” Desai stated. “In sufferers who require remedy by means of surgical procedure, shut to 1 in two would require retreatment inside 5 years.”
Concerning the Ethicon Monarch platform
Ethicon designed the Monarch robot-assisted surgical platform to allow urologists to achieve and visualize areas inside the kidney with precision and management. The system affords one platform for supporting each ureteroscopic and PCNL procedures.
The Monarch platform for urology permits for navigation by means of the kidney with a handheld controller. Robotic help offers surgeons a technique to exactly keep instrument positions and carry out a number of duties concurrently. It makes use of a novel electromagnetic concentrating on platform to present urologists extra exact entry to the kidney.
Based on Ethicon, Monarch supplies 80% much less radiation publicity throughout percutaneous entry in comparison with normal fluoroscopic-guided entry methods. It additionally affords consistency with fewer needle sticks when acquiring entry, the corporate stated.
“After years of labor, we’re thrilled to be part of this primary scientific sequence which introduces a brand new remedy to enhance outcomes for sufferers in want,” Landman stated.
Editor’s Be aware: This text first appeared on sister web site MassDevice.